Prostate cancer Board decisions

The appeal for service connection of prostate cancer is remanded. The VA will obtain necessary medical records and conduct an examination to determine if the cancer is related to service.

The Veteran's claims for service connection for erectile dysfunction, headaches, and sleep apnea have been raised by the record.,The Board has remanded these issues to allow for further development.

The Veteran's claims for service connection for prostate cancer, left adrenal gland cancer, and a higher rating for right kidney cancer have been sent back to the VA for further review.

The Board remanded the veteran's claims for service connection for atrial fibrillation, prostate cancer, and COPD due to inadequate medical nexus opinions. The veteran will receive a new decision after additional evidence is obtained.

The veteran's effective date for service connection of prostate cancer has been granted as September 2, 2021. This is based on the veteran's exposure to herbicides during his service in Vietnam.

The Board remanded the claim for service connection of prostate cancer due to inadequate medical opinion. The Veteran's exposure to Camp Lejeune water is considered, but prostate cancer is not on the presumptive list.

The veteran's claims for service connection for sickle cell retinopathy and an acquired psychiatric disorder were granted. The claims for left leg gout and right leg gout were denied. The issues of hypertension, prostate cancer, and bilateral pes planus were remanded.

The veteran's claim for service connection for prostate cancer and erectile dysfunction (ED) secondary to prostate cancer, both pursuant to the PACT Act, is granted. The claims for service connection for prostate cancer and ED prior to the PACT Act are remanded.

The veteran's service connection for diabetes mellitus type II and related conditions was granted with an effective date of September 23, 2013. Service connection for prostate cancer and hypertension was also granted. However, higher disability ratings were denied, and some issues were remanded.

The appeals for service connection of right leg clot deep vein thrombosis (DVT), type 2 diabetes mellitus, prostate cancer, atrial fibrillation lung clot, and erectile dysfunction were dismissed due to the Veteran's death.

The veteran's claim for an earlier effective date for Total Disability based on Individual Unemployability (TDIU) due to service-connected prostate cancer residuals was granted, with the effective date set to August 23, 2010.

The Board remanded the veteran's claims for service connection of Parkinson's disease, prostate cancer, urinary incontinence, and erectile dysfunction due to participation in a toxic exposure risk activity (TERA).

The Board has remanded the claims for service connection for prostate cancer and sleep apnea due to inadequate medical opinions. The Veteran's spouse is now represented in this appeal.

The Veteran's claim for service connection for anemia was denied. The claims for prostate cancer, proctitis, penile implant, CIDP, psoriasis, psoriatic arthritis, and prurigo nodularis were remanded.

The Board remanded the veteran's claims for service connection of prostate cancer, colon cancer, and skin cancer. The Board requested additional medical opinions to determine if these conditions are related to the veteran's military service.

The appeal for service connection of pancreatitis and evaluation of prostate cancer residuals, voiding dysfunction was dismissed due to the Veteran's death.

Service connection for prostate cancer due to herbicide exposure is granted.

The veteran's prostate cancer is service-connected due to herbicide exposure. The claim for bilateral hearing loss is sent back for more evidence.

The veteran's claim for an earlier effective date for service connection for erectile dysfunction and residuals of prostate cancer was denied. However, the veteran was granted an effective date of April 4, 2022, for special monthly compensation (SMC) based on loss of use of a creative organ.

The Veteran's chronic myelogenous leukemia (CML) is service-connected because it was caused or aggravated by their service-connected prostate cancer residuals (PCR).